PTC Therapeutics
PTCT
#3089
Rank
NZ$9.38 B
Marketcap
NZ$112.30
Share price
-2.68%
Change (1 day)
-15.61%
Change (1 year)

EPS for PTC Therapeutics (PTCT)

EPS in 2026 (TTM): NZ-$2.26

According to PTC Therapeutics 's latest financial reports the company's current EPS (TTM) is NZ-$2.38. In 2025 the company made an earnings per share (EPS) of NZ$15.98 an increase over its 2024 EPS that were of NZ-$8.60.

EPS history for PTC Therapeutics from 2014 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$2.26-114.12%
2025NZ$15.98-285.84%
2024NZ-$8.60
2022NZ-$14.164.85%
2021NZ-$13.50
2019NZ-$8.1266.17%
2018NZ-$4.8929.33%
2017NZ-$3.78-50.12%
2016NZ-$7.58-17.59%
2015NZ-$9.2057.63%
2014NZ-$5.83

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
NZ$9.54-500.76%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vertex Pharmaceuticals
VRTX
NZ$28.48-1,296.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
NZ-$2.85 19.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
NZ-$4.78 100.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
NZ-$1.91-19.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNAM
NZ-$7.60 219.08%๐Ÿ‡บ๐Ÿ‡ธ USA